Brooklyn ImmunoTherapeutics Inc

NASDAQ:BTX   3:59:50 PM EDT
5.69
+0.20 (+3.64%)
Earnings Announcements

Brooklyn Immunotherapeutics Posts Quarterly Loss Per Share Of $1.70

Published: 11/09/2021 23:37 GMT
Brooklyn ImmunoTherapeutics Inc (BTX) - Brooklyn Immunotherapeutics Announces Third Quarter 2021 Financial Results.
Brooklyn Immunotherapeutics Inc - As of September 30, 2021, Brooklyn Had Approximately $24.4 Million in Cash.
Brooklyn Immunotherapeutics Inc Qtrly Loss per Share $1.70.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.09

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.